Literature DB >> 29897401

Radio-pharmaceuticals for cancer treatment: are they ready for prime time yet?

R Turck1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29897401     DOI： 10.1093/annonc/mdy142

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Unsealed Source: Scope of Practice for Radiopharmaceuticals Among United States Radiation Oncologists.

Authors:  Utkarsh Shukla; Imran H Chowdhury; Jason M Beckta; Jacob S Witt; Matthew McFarlane; Chelsea J Miller; Kathryn E Huber; Matthew S Katz; Trevor J Royce; Mudit Chowdhary
Journal:  Adv Radiat Oncol       Date:  2021-10-26

Review 2.  More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond.

Authors:  Anniina Hyväkkä; Verneri Virtanen; Jukka Kemppainen; Tove J Grönroos; Heikki Minn; Maria Sundvall
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

Review 3.  The Interplay among Radiation Therapy, Antibiotics and the Microbiota: Impact on Cancer Treatment Outcomes.

Authors:  Kavery Nivana Theethira Poonacha; Tomás G Villa; Vicente Notario
Journal:  Antibiotics (Basel)       Date:  2022-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.